SAQ. In the third trimester, a pregnant woman develops jaundice, thought to be caused by antihypertensive drugs.
- Which is the most likely drug that may cause jaundice? What is the mechanism
- Likely drug: Alpha methyldopa
Mechanism of Hepatotoxicity:
- Autoimmune mechanism
- Metabolic studies suggest that methyldopa may induce an autoimmune liver injury (perhaps via a toxic metabolic intermediate serving as an antigenic hapten presented on the surface of hepatocytes) in susceptible hosts.
- How will you investigate to support your diagnosis?
Investigations :
The acute liver injury within 2 -12 weeks of starting therapy.
Investigations | Interpretation |
|
|
HBsAg, anti HCV,
anti HAV, anti HEV |
|
ANA, Coombs test |
|
Liver biopsy |
|
Management of hypertension in pregnancy:
Non- pharmacological
- Regular exercise may be continued
- For obese women: advised to avoid weight gain of more than 6-8 kg
Pharmacological:
- Drugs of choice (Contraindicated: ACEI, ARB, Diuretics)
- Methyldopa
- Beta blockers (Labetalol)
- CCB (Nifedipine, amlodipine)
- Doxazosin
- Prevention of HTN and pre-eclampsia:
- High or moderate risk of pre-eclampsia: 100-150 mg of Aspirin daily from week 12 to weeks 36-37 of pregnancy
- Calcium supplementation: 1.5-2 gm/day is recommended for prevention of pre-eclampsia in women with low dietary intake of calcium (<600 mg/day), to be commenced at the first antenatal clinic.
- For prevention & Rx of eclampsia: IV MgSO4 (but not with CCB)
- Rx of severe HTN
- Hospitalization is indicated
- Anti-HTN drug & route of administration depends on expected time of delivery
- IV Labetalol/oral Methyldopa/Nifedipine should be initiated
- Na-nitroprusside is the drug of last choice, due to risk of fetal cyanide poisoning
- Preeclampsia associated with pulmonary oedema: nitroglycerine IV infusion
- Delivery: Indicated in
- Pre-eclampsia with visual disturbances or hemostatic disorders
- At 37 weeks in asymptomatic woman
Preeclampsia:
- Control of blood pressure,
- IV magnesium sulfate as prophylaxis against seizures.
- Correction of coagulation abnormalities
- Monitoring of fluid balance.
- If these measures are ineffective and eclampsia supervenes
- urgent delivery
Eclampsia
- It usually presents with seizures on a background of pre-eclampsia but rarely can occur before the onset of hypertension and proteinuria.
- Treatment:
- Anti hypertensives
- IV magnesium sulfate (Inf. Nalepsin 4 gm/100 ml) 4 g, over 15 mins followed by an infusion of 1 g/hr titrated to serum magnesium for 24 h.
- Correction of coagulation abnormalities.
- Monitoring of fluid balance.
- Delivery of the fetus as soon as possible.
Prognosis:
- Women with pre-eclampsia are more likely to develop HTN, CKD, IHD, cerebrovascular in later life.